Profile
ABCM VRTX REGN ALNY SGEN ARGX
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 1.76K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABCM VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 4 1 3 2
Quant Rating Sell Buy Strong Sell Neutral Sell
Trading
ABCM VRTX REGN ALNY SGEN ARGX
Last Close $23.99 $459.81 $542.52 $320.53 $228.74 $564.59
High 52 $23.99 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $23.99 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High 0 % -11.02 % -54.86 % -3.43 % 0 % -15.95 %
Price vs. 52 Week Low 0 % 15.93 % 12.34 % 42.72 % 0 % 22.47 %
Total Return
ABCM VRTX REGN ALNY SGEN ARGX
1 Month Return 0 % 2.54 % 5.63 % 2.63 % 0 % 4.96 %
3 Month Return 0 % -5.99 % -3.67 % 36.65 % 0 % -5.3 %
6 Month Return 0 % 8.96 % -20.4 % 30.15 % 0 % -11.85 %
9 Month Return 0 % -4.8 % -45.24 % 8.31 % 0 % -0.07 %
YTD Return 0 % 14.18 % -23.84 % 36.22 % 0 % -8.2 %
1 Year Return 0 % -6.46 % -48.99 % 34.77 % 0 % 19.79 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ABCM VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 71.21 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM 0.45 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 0.76 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM 0.8 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 93.62 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 73.44 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM 2.03 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM 27.38 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 7.04 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM 1.56 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 195.05 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 31.98 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM 0.3 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM 0.01 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 45.81 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM 19.94 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM 27.38 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM - -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM 40.46 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM 40.46 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
ABCM VRTX REGN ALNY SGEN ARGX
Revenue $0.36B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.27B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 74.79% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $0.04B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.04 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABCM VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.1B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.33B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.73B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.22B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $1.06B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
ABCM VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $-0.01B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $-0.03B $0B $0B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0.04B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.39
AARD Aardvark Therapeutics, Inc. Common Stock 11.62
ABCL AbCellera Biologics Inc. 4.48
ABEO Abeona Therapeutics Inc. 6.59
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.0225
ABSI Absci Corporation 3.12
ABUS Arbutus Biopharma Corporation 3.13
ABVC ABVC BioPharma, Inc. 3.35
ABVX Abivax SA American Depositary Shares 9.95
ACAD ACADIA Pharmaceuticals Inc. 22.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7595
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.68
ACIU AC Immune SA 2.07
ACLX Arcellx, Inc. 67.59
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 129.73
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 40.22
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 49.1234
MNA IQ Merger Arbitrage ETF 6.85 35.29
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 82.28
FPXI First Trust International Equity Opportunities ETF 0.45 55.8817
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 38.89
MRGR ProShares Merger ETF 3.16608 42.38
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 31.6
VINEX Vanguard International Explorer Fund Investor Shares 0.22 19.68
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 71.55
VGHCX Vanguard Health Care Fund Investor Shares 0.36 169.69
BMED BlackRock Future Health ETF 1.68229 24.9361
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 21.9211
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 5.57
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.48375
DFIC Dimensional International Core Equity 2 ETF 0.00052105 30.89
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.457
CTRU ARK Transparency ETF 0.96 12.897
Unlock